Phone: (516) 487-8207
The medical community has edged closer this week to treating prostate cancer with a certainty unknown before.
The research involves the identification of five genes, which indicate whether a patient's prostate cancer will become aggressive or not. 250,000 men in the United States each year are diagnosed with prostate cancer, but only one percent suffer a potentially fatal form of the disease. Men with four or five of the genes in question were 50% more likely to develop an aggressive form of the disease than those with one, two, or none of the genes.
Doctors and patients have been in the dark without this knowledge. Now, once prostate cancer is diagnosed, the manner of treatment becomes less of a guessing game, as doctors are able to take genetic information, along with other information, like the stage of the disease, to determine the best form of treatment.
The study, conducted for six and a half years at New York's Cold Spring Harbor Laboratory, found genes like PHLPP1 and PTEN through process of elimination among a test group of prostate cancer patients. They then researched relationships between the genes . The data was published in the August 16th issue of Cancer Cell.
MORE INFORMATION
If you would like more information about how medical malpractice cases work in the state of New York, I encourage you to explore my educational website. If you have legal questions, I urge you to pick up the phone and call me at 516-487-8207 or by e-mail at lawmed10@yahoo.com to answer your questions. That's what I do every day. I welcome your call.
Read More About Study: Genetic Markers Indicate Prostate Cancer Danger Level...
